A calcium score test can help clarify a statin decision when you have no known cardiovascular disease, your estimated risk is borderline or intermediate, and you and your clinician remain unsure about treatment. It adds a measure of calcified plaque to your risk picture. It does not diagnose every kind of heart disease, and a score of zero is not a guarantee that you are risk-free.
How a calcium score test changes a statin discussion
The test is a short, non-contrast CT scan that looks for calcium in the coronary arteries. The amount is usually reported as an Agatston score. A higher score generally means more calcified plaque and higher future cardiovascular risk; a zero means the scan detected none. The result is most useful alongside your age, cholesterol, blood pressure, smoking status, diabetes, family history and estimated risk—not on its own.
US ACC/AHA guidance supports considering CAC when a statin decision remains uncertain for some adults at borderline or intermediate 10-year risk. A score above zero can strengthen the case for treatment, especially at higher levels. A score of 100 or more, or a result high for your age and sex, is a strong reason to discuss statin therapy. These cut-offs inform a conversation; they are not a complete treatment plan.
Recommendations are not identical everywhere. European Society of Cardiology guidance allows CAC to help reclassify risk in selected people at low or moderate risk when medication is being considered after lifestyle measures. Other regional pathways may differ, as can scan availability and cost. A Canadian cost-effectiveness model found that a CAC-guided approach could be cost-effective over 10 years in its modeled population, but that does not establish that scanning is affordable or accessible in every health system.
What a score of zero does—and does not—mean
In people without symptoms or known cardiovascular disease, zero is reassuring: it is associated with low coronary event rates over the following years. For some people whose statin decision is uncertain, that result may support delaying treatment while continuing to manage risk factors. It does not erase risks from high cholesterol, blood pressure or smoking, and it does not mean there is no plaque at all. The scan detects calcified plaque, not all non-calcified plaque; this distinction matters particularly in younger adults.
A zero score should not automatically settle the decision if you have diabetes, smoke, have a strong family history of premature cardiovascular disease, or have very high LDL cholesterol—around 190 mg/dL (4.9 mmol/L) or above. These factors can still support treatment discussions despite a zero result. Keep working on the risk factors you can address, and review the result with a clinician who knows your history.
When might repeat scanning be considered?
A zero score describes what the scan found at that time, not what it will show indefinitely. Repeat imaging may be considered if your risk remains uncertain and the result could change a treatment decision. Timing is not settled into one universal schedule: some proposed guidance suggests about 3–5 years for people at intermediate risk, while other recommendations use longer intervals or tailor timing to risk. A repeat scan is not automatically needed; ask what decision it would inform and whether the result would change your care.
Know the scan’s limits and trade-offs
A CAC scan is intended for risk assessment in people without symptoms, not as a test to investigate chest pain, breathlessness or other possible heart symptoms. It also does not replace assessment for known coronary disease or a prior heart attack. A zero score cannot safely rule out a cause of symptoms. If you have new, severe or worsening symptoms, seek medical care rather than arranging a screening scan.
The scan uses ionizing radiation. The dose is generally low—often reported as under 1 mSv—but it varies with the scanner and protocol. The images can also reveal findings outside the heart. Some incidental findings prompt follow-up tests, costs or worry, even when they turn out not to be serious.
Before booking, ask your clinician whether your risk estimate and risk-enhancing factors leave a genuine decision unresolved, what different results would mean for you, and whether the scan is available and covered where you live. If the answer would not change the plan, the scan may add little.
